Lenacapavir
Lenacapavir (GS-6207) is a HIV-1 capsid inhibitor. Lenacapavir shows anti-HIV activity with an EC50 of 100 pM in MT-4 cells. Lenacapavir displays a mean EC50 of 50 pM (20-160 pM) against 23 HIV-1 clinical isolates from different subtypes in peripheral blood mononuclear cells (PBMCs) [1]. Lenacapavir is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Product Specifications
CAS Number
2189684-44-2
Product Name Alternative
GS-6207
UNSPSC
12352005
Hazard Statement
H315, H319, H320
Target
HIV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/gs-6207.html
Concentration
10mM
Purity
98.44
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
Molecular Formula
C39H32ClF10N7O5S2
Molecular Weight
968.28
Precautions
H315, H319, H320
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
HIV-1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human BPI (Bactericidal/Permeability Increasing Protein) CLIA Kit
Human BPI (Bactericidal/Permeability Increasing Protein) CLIA Kit
Human BPI (Bactericidal/Permeability Increasing Protein) CLIA Kit
GLUT-1 (Tumor Progression and Mesothelioma Marker) (GLUT1/2475), CF594 conjugate, 0.1mg/mL
